As a result, 71 California-based staffers—or 13% of the company’s overall U.S. workforce—are set to lose their jobs, Ajinomoto said in a memo viewed by Fierce Pharma.
https://www.fiercepharma.com/pharma/ajinomoto-will-lay-71-staffers-ca-streamline-cdmo-business-following-620m-forge-biologics